Purpose To evaluate the incidence and identify the risk factors for radiotherapy-induced oral
mucositis among patients with nasopharyngeal carcinoma. Methods A meta-analysis was …

Oropharyngeal mucositis is an acute and distressing toxic effect of chemotherapy and head
and neck irradiation. This oral sequela significantly impairs the daily functioning and quality …

In this review, potential benefits of pentoxifylline (PTX) on wound healing have been
evaluated. All available experimental and clinical studies examined effects of PTX on wound …

Iseganan HCl is an antimicrobial peptide under development for the prevention of oral
mucositis, a severe consequence of some chemotherapy and radiation therapy regimens …

Radiation induced oral mucositis (RIOM) is a common and debilitating complication of
radiation therapy for head and neck cancers. RIOM can lead to oral pain, dysphagia, and …

Purpose: The purpose of this study was to evaluate the activity of CG53135 (FGF-20), a
protein with in vitro mitogenic activity on epithelial and mesenchymal cells, in two in vivo …

Purpose To evaluate the effect of the anti-fibrotic protein serum amyloid P (SAP) on radiation-
induced oral mucositis (OM) and fibrosis in a hamster cheek-pouch model. Experimental …

In this multicenter study, we assessed the use of palifermin (recombinant human–
keratinocyte growth factor 1) in the prevention of oral mucositis (OM) and acute GvHD …

Oral mucositis is a common, treatment-limiting, and costly side effect of cancer treatments
whose biological underpinnings remain poorly understood. In this study, mucositis induced …

PURPOSE: A multi-center prospective randomized trial was conducted to evaluate the
efficacy and safety of Actovegin in the prevention and treatment of chemoradiotherapy …